Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT04559984 | JUVÉDERM VOLUX® for Chin Retrusion in China | PHASE3 | COMPLETED | 150 | — | — | Oct 15, 2020 | Aug 26, 2022 | Aug 21, 2023 | 7 | China |
The G-Sn-Pog angle is the angle formed by the point on the glabella, subnasale, and pogonion.
| Arm | Type | Description |
|---|---|---|
| JUVÉDERM VOLUX® | EXPERIMENTAL | Participants will be treated with VOLUX XC hyaluronic acid (HA) injectable gel on day 1 with an optional touch-up treatment at week 4 if agreed upon by both the participant and Treating Investigator. |
| Control- No treatment | OTHER | No-treatment during the control period. Optional delayed-treatment with VOLUX XC (initial with optional touch-up) during the Post-Control period. |
| Name | Type | Description |
|---|---|---|
| JUVÉDERM VOLUX® | DEVICE | JUVÉDERM VOLUX® injectable gel |
Inclusion Criteria: * Participant must be at least 18 years of age at the time of signing the ICF * Male and female * Participants of Chinese descent * Participants seeking improvement of chin retrusion * Chin retrusion (G-Sn-Pog angle of \< 172.5°) based on calculations of facial angle derived fro...